product summary
Loading...
company name :
Tocris Bioscience
product type :
chemical
product name :
Ch 55
catalog :
2020/10
quantity :
10 mg (also 50 mg)
price :
220 USD
more info or order :
citations: 2
| Reference |
|---|
product information
brand :
Tocris
catalog number base :
2020
SKU :
2020/10
product name :
Ch 55
units size :
10 mg (also 50 mg)
description :
Potent RAR agonist
target :
Retinoic Acid Receptor Agonists
category :
Small Molecules
purity :
98%
observed molecular weight :
364.47
url print :
?utm_source=biocompare&utm_medium=referral&utm_campaign=product&utm_term=smallmolecules
review stars :
4
details of functionality :
Ch 55 is a highly potent synthetic retinoid that has high affinity for RAR- and RAR- receptors and low affinity for cellular retinoic acid binding protein (CRABP). Inhibits rabbit tracheal epithelial cell differentiation by inhibiting transglutaminase and increasing cholesterol sulfate (EC50 values are 0.02 and 0.03 nM respectively). Induces differentiation of embryonic carcinoma F9 and melanoma S91 cells (EC50 values are 0.26 and 0.5 nM respectively) and inhibits the induction of ornithine decarboxylase activity in 3T6 fibroblasts (EC50 = 1 nM). Enables generation of Chemically Induced Pluripotent Stem Cells (CiPSCs) from mouse embryonic fibroblasts (MEFs) (see our protocol below). . For more information about how Ch 55 may be used, see our protocol: Highly Efficient Generation of CiPSCs from MEFs
top caption :
Potent RAR agonist
extended description :
Potent RAR agonist
chemical name text :
4-[(1E)-3-[3,5-bis(1,1-Dimethylethyl)phenyl]-3-oxo-1-propenyl]benzoic acid
formula :
C24H28O3
formula text :
C24H28O3
cas num :
110368-33-7
USD :
220 USD
product details :
Potent RAR agonist
storage :
Store at RT
more info or order :
company information

Tocris Bioscience
The Watkins Building
Atlantic Road
Avonmouth, Bristol
BS11 9QD
Atlantic Road
Avonmouth, Bristol
BS11 9QD
info@bio-techne.com
https://www.tocris.com800-343-7475
headquarters: UK
related products
browse more products
questions and comments
